Drug Shortage Report for FOQUEST

Last updated on 2024-03-06 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2024-08-30
Actual end date
Shortage status Actual shortage
Updated date 2024-03-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v115 2023-06-08 French Compare
v114 2023-06-08 English Compare
v113 2023-05-26 French Compare
v112 2023-05-26 English Compare
v111 2023-05-18 French Compare
v110 2023-05-18 English Compare
v109 2023-05-12 French Compare
v108 2023-05-12 English Compare
v107 2023-05-05 French Compare
v106 2023-05-05 English Compare
v105 2023-05-04 French Compare
v104 2023-05-04 English Compare
v103 2023-05-01 French Compare
v102 2023-05-01 English Compare
v101 2023-04-21 French Compare
v100 2023-04-21 English Compare
v99 2023-04-18 French Compare
v98 2023-04-18 English Compare
v97 2023-04-13 French Compare
v96 2023-04-13 English Compare

Showing 41 to 60 of 155